Ledger.Open graph →
SEC Form D · filed February 1, 2022

FireCyte Therapeutics, Inc

Offering
$12.0M
Sold
$5.5M
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Meredith E. Fisher · Cambridge, MADirectorRuoxi E. Hu · Cambridge, MADirectorWilliam E. Yelle · Cambridge, MAExec · DirectorCharles E. Kunsch · Cambridge, MADirectorMeredith E. Fisher · Cambridge, MADirectorRuoxi E. Hu · Cambridge, MADirectorWilliam E. Yelle · Cambridge, MAExec · DirectorCharles E. Kunsch · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗